Morgan Stanley Knock-Out GS/ DE000MB8YSM2 /
2024-06-05 4:21:55 PM | Chg.+0.45 | Bid4:43:31 PM | Ask4:43:31 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
18.52EUR | +2.49% | 18.54 Bid Size: 5,000 |
18.57 Ask Size: 5,000 |
Goldman Sachs Group ... | 259.447 USD | 2078-12-31 | Call |
GlobeNewswire
2:00 PM
Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
1:30 PM
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
1:00 PM
SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
1:00 PM
Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare C...
GlobeNewswire
1:00 PM
Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
1:00 PM
Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
1:00 PM
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-04
Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-04
Ultragenyx to Participate at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-04
Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-04
Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05-09
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
04-11
C.K. McWhorter Continues Goldman Sachs Communications: Potential Strong Partnership Ties